Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

This was revealed by the King Cetshwayo District Municipality during its annual report presentation last week. KCDM is the water service authority to four municipalities in the region, including ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will host its 2025 Annual Meeting ...

The need for a stronger Europe is greater than ever due to the threat of a global trade war and unrest in the world, president Klaas Knot of De Nederlandsche Bank (DNB) said during the presentation of ...

Continued growth and solid EBITDA margin Columbus' revenue amounted to DKK 1,659m in 2024, corresponding to an increase of 8%. Organically ...

Following the formal business and voting portion of the Meeting, Anixa Chairman and CEO Dr. Amit Kumar, will deliver an investor presentation ... of our most recent Annual Report on Form 10 ...

Columbus’ revenue amounted to DKK 1,659m in 2024, corresponding to an increase of 8%. Organically, revenue grew by 7%. EBITDA increased by 30% to DKK 153m. Most of our global Business Lines have been ...

Wacker Chemie AG reported that its 2024 sales and earnings fell versus the previous year due to persistently weak market conditions. WACKER’s sales totaled €5.72 billion, 11 percent less than in 2023 ...

Team members with the Giant Mine Remediation Project gave an annual presentation at the City of Yellowknife's governance and ...

The poster presentation from AAVantgarde’s Stargardt program will report preliminary data from the NHP GLP study, designed to evaluate the safety and pharmacokinetics of subretinal administration of ...

Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...